|
TOMM22 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.003600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.474200E-01 |
| Normal-vs-Stage2 |
6.082400E-01 |
| Normal-vs-Stage3 |
4.935600E-02 |
| Normal-vs-Stage4 |
9.503400E-01 |
| Stage1-vs-Stage2 |
8.073200E-01 |
| Stage1-vs-Stage3 |
1.003890E-02 |
| Stage1-vs-Stage4 |
6.923800E-01 |
| Stage2-vs-Stage3 |
1.282590E-01 |
| Stage2-vs-Stage4 |
6.552000E-01 |
| Stage3-vs-Stage4 |
9.050300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.974800E-01 |
| Normal-vs-AfricanAmerican |
3.957400E-04 |
| Normal-vs-Asian |
6.359200E-01 |
| Caucasian-vs-AfricanAmerican |
2.4734999999998E-05 |
| Caucasian-vs-Asian |
7.050400E-01 |
| AfricanAmerican-vs-Asian |
2.464600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.321200E-01 |
| Normal-vs-Female |
8.674800E-01 |
| Male-vs-Female |
9.326400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.748800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.991600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.245200E-01 |
| Normal-vs-Age(81-100Yrs) |
4.847600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.700600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.386600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.106000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.100400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.016200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.965600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.153820E-01 |
| Normal-vs-Grade 2 |
8.551400E-01 |
| Normal-vs-Grade 3 |
9.531200E-01 |
| Normal-vs-Grade 4 |
1.644180E-01 |
| Grade 1-vs-Grade 2 |
7.717900E-02 |
| Grade 1-vs-Grade 3 |
1.100630E-01 |
| Grade 1-vs-Grade 4 |
6.356000E-01 |
| Grade 2-vs-Grade 3 |
8.084200E-01 |
| Grade 2-vs-Grade 4 |
1.080420E-01 |
| Grade 3-vs-Grade 4 |
1.961650E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.410360E-02 |
| Normal-vs-ccB subtype |
3.202300E-02 |
| ccA subtype-vs-ccB subtype |
3.26429999997213E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.095400E-01 |
| Normal-vs-N1 |
7.827400E-01 |
| N0-vs-N1 |
7.320400E-01 |
|
|
